Skip to main content
padlock icon - secure page this page is secure

Publisher: Wiley-Blackwell

Volume 23, Number 4, 1 December 2018

Second IVIg course in Guillain‐Barré syndrome patients with poor prognosis (SID‐GBS trial): Protocol for a double‐blind randomized, placebo‐controlled clinical trial
pp. 210-215(6)
Authors: Walgaard, Christa; Jacobs, Bart C.; Lingsma, Hester F.; Steyerberg, Ewout W.; Cornblath, David R.; van Doorn, Pieter A.; the Dutch GBS Study Groupjns12286-cr-0007

Favourites:
ADD

Clinical and genetic investigation in Chinese patients with demyelinating Charcot‐Marie‐Tooth disease
pp. 216-226(11)
Authors: He, Jin; Guo, Lingling; Xu, Guorong; Xu, Liuqing; Lin, Shan; Chen, Wanjin; Wang, Ning

Favourites:
ADD

Clinical relevance of serum antibodies to GD1b in immune‐mediated neuropathies
pp. 227-234(8)
Authors: Taams, Noor E.; Notermans, Nicolette C.; Fokkink, Willem‐Jan R.; Tio‐Gillen, Anne P.; Huizinga, Ruth; Schreurs, Marco W. J.; Jacobs, Bart C.

Favourites:
ADD

Rituximab in chronic inflammatory demyelinating polyradiculoneuropathy with associated diseases
pp. 235-240(6)
Authors: Roux, Thomas; Debs, Rabab; Maisonobe, Thierry; Lenglet, Timothée; Delorme, Cécile; Louapre, Céline; Leblond, Véronique; Viala, Karine

Favourites:
ADD

Nociceptin/orphanin FQ opioid peptide‐receptor expression in pachyonychia congenita
pp. 241-248(8)
Authors: Pan, Baohan; Schröder, Wolfgang; Jostock, Ruth; Schwartz, Mary; Rosson, Gedge; Polydefkis, Michael

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more